Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/22/24
End: 12/29/27
Due: 12/29/28
Phase: N/A
Priority: Normal
Start: 03/05/25
End: 08/31/29
Due: 08/31/30
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors | NCT06533059 | Alterome Therapeutics, Inc. | user2@example.com | None | 2024-08-22 | 2027-12-29 | 2028-12-29 | - | - | 2025-07-14 |
| A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations | NCT06835569 | Alterome Therapeutics, Inc. | user2@example.com | None | 2025-03-05 | 2029-08-31 | 2030-08-31 | - | - | 2025-07-14 |